Literature DB >> 2428941

A proposal for a classification of neuropathies according to their axonal transport abnormalities.

J Jakobsen, P Sidenius, H Braendgaard.   

Abstract

Recent studies on axonal transport in experimental neuropathy are reviewed and the following combinations of pathological changes and underlying axonal transport abnormalities are proposed for a classification of polyneuropathies. Alterations of the anterograde transport of slow component a(SCa) leads to changes of the dimensions of the axon calibre without the occurrence either of overt neuropathy or fibre loss. Thus damming of SCa in beta,beta'-iminodiproprionitrile (IDPN) intoxication results in axonal swelling in nerve roots whereas decrease of SCa leads to atrophy distal to the swellings in IDPN intoxication and in streptozotocin induced diabetes as well. Decrease in the amount of material conveyed within the anterograde fast component (aFC) leads to acute axonal degeneration including break down of axons and fibre loss. This state occurs in acute hypoglycaemia and in doxorubicin intoxication. The most frequent type of polyneuropathy, namely distal axonopathy with accumulation of axon organelles leading to distal fibre loss, is associated with decrease in amount of the retrograde fast component (rFC). The transport is impaired before the appearance of symptoms and electrophysiological signs of neuropathy develop in the intoxications induced by parabromophenylacetylurea, acrylamide and 2.5 hexanedione, and the severity of neuropathy is proportional to the rFC impairment.

Entities:  

Mesh:

Year:  1986        PMID: 2428941      PMCID: PMC1028999          DOI: 10.1136/jnnp.49.9.986

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  39 in total

1.  Segmental demyelination secondary to axonal degeneration in uremic neuropathy.

Authors:  P J Dyck; W J Johnson; E H Lambert; P C O'Brien
Journal:  Mayo Clin Proc       Date:  1971-06       Impact factor: 7.616

2.  The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies.

Authors:  W G Bradley; L P Lassman; G W Pearce; J N Walton
Journal:  J Neurol Sci       Date:  1970-02       Impact factor: 3.181

3.  The neuromyopathy of vincristine in the guinea pig. An electrophysiological and pathological study.

Authors:  W G Bradley
Journal:  J Neurol Sci       Date:  1970-02       Impact factor: 3.181

4.  Retrograde axoplasmic transport: its continuation as anterograde transport.

Authors:  T Abe; T Haga; M Kurokawa
Journal:  FEBS Lett       Date:  1974-10-15       Impact factor: 4.124

5.  Axoplasmic flow in axonal neuropathies. I. Axoplasmic flow in cats with toxic neuropathies.

Authors:  W G Bradley; M H Williams
Journal:  Brain       Date:  1973-06       Impact factor: 13.501

6.  Dependence of fast axoplasmic transport in nerve on oxidative metabolism.

Authors:  S Ochs; D Hollingsworth
Journal:  J Neurochem       Date:  1971-01       Impact factor: 5.372

7.  The experimental neuropathy in rats caused by p-bromophenylacetylurea.

Authors:  J B Cavanagh; F C Chen; M H Kyu; A Ridley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-10       Impact factor: 10.154

8.  Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and mice.

Authors:  R L Friede; T Samorajski
Journal:  Anat Rec       Date:  1970-08

9.  Altered axonal transport of cytoskeletal proteins in the mutant diabetic mouse.

Authors:  M Vitadello; G Filliatreau; J L Dupont; R Hassig; A Gorio; L Di Giamberardino
Journal:  J Neurochem       Date:  1985-09       Impact factor: 5.372

10.  The slow component of axonal transport. Identification of major structural polypeptides of the axon and their generality among mammalian neurons.

Authors:  P N Hoffman; R J Lasek
Journal:  J Cell Biol       Date:  1975-08       Impact factor: 10.539

View more
  7 in total

1.  Pressure-induced inhibition of fast axonal transport of proteins in the rabbit vagus nerve in galactose neuropathy: prevention by an aldose reductase inhibitor.

Authors:  W G McLean
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

2.  Depletion of cutaneous nerves and neuropeptides in diabetes mellitus: an immunocytochemical study.

Authors:  D M Levy; S S Karanth; D R Springall; J M Polak
Journal:  Diabetologia       Date:  1989-07       Impact factor: 10.122

3.  Abnormal centrifugal axons in streptozotocin-diabetic rat retinas.

Authors:  M J Gastinger; A J Barber; S A Khin; C S McRill; T W Gardner; D W Marshak
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-10       Impact factor: 4.799

4.  The effects of Ginkgo biloba extract (GBe) on axonal transport microvasculature and morphology of sciatic nerve in streptozotocin-induced diabetic rats.

Authors:  J Kim; K Yokoyama; S Araki
Journal:  Environ Health Prev Med       Date:  2000-07       Impact factor: 3.674

5.  Early increase in CGRP- and VIP-immunoreactive nerves in the skin of streptozotocin-induced diabetic rats.

Authors:  S S Karanth; D R Springall; S Francavilla; D J Mirrlees; J M Polak
Journal:  Histochemistry       Date:  1990

6.  Immunotactoid-like endoneurial deposits in a patient with monoclonal gammopathy of undetermined significance and neuropathy.

Authors:  D F Moorhouse; R I Fox; H C Powell
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Giant axonopathy in streptozotocin diabetes of rats.

Authors:  I Jirmanová
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.